ECSP045322A - FORMULATIONS OF AN HID SUSPENSION WITH HFA - Google Patents

FORMULATIONS OF AN HID SUSPENSION WITH HFA

Info

Publication number
ECSP045322A
ECSP045322A EC2004005322A ECSP045322A ECSP045322A EC SP045322 A ECSP045322 A EC SP045322A EC 2004005322 A EC2004005322 A EC 2004005322A EC SP045322 A ECSP045322 A EC SP045322A EC SP045322 A ECSP045322 A EC SP045322A
Authority
EC
Ecuador
Prior art keywords
hfa
hid
formulations
suspension
hydroxidi
Prior art date
Application number
EC2004005322A
Other languages
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ECSP045322A publication Critical patent/ECSP045322A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La invención se refiere a formulaciones con gas portador que contienen suspensiones del anhidrato cristalino de bromuro de (1a,2b,4b,5a,7b)-7-[(hidroxidi-2- -tienilacetil)oxi]-9,9-dimetil-3-oxa-9-azonia-triciclo[3.3.1.02,4]nonano.The invention relates to carrier gas formulations containing suspensions of the crystalline bromide anhydrate of (1a, 2b, 4b, 5a, 7b) -7 - [(hydroxidi-2--thienylacetyl) oxy] -9,9-dimethyl- 3-oxa-9-azonia-tricycle [3.3.1.02.4] nonane.

EC2004005322A 2002-03-28 2004-09-28 FORMULATIONS OF AN HID SUSPENSION WITH HFA ECSP045322A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10214264A DE10214264A1 (en) 2002-03-28 2002-03-28 HFA suspension formulations of an anhydrate

Publications (1)

Publication Number Publication Date
ECSP045322A true ECSP045322A (en) 2005-01-28

Family

ID=28050990

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005322A ECSP045322A (en) 2002-03-28 2004-09-28 FORMULATIONS OF AN HID SUSPENSION WITH HFA

Country Status (21)

Country Link
EP (1) EP1492498A2 (en)
JP (1) JP5147158B2 (en)
KR (1) KR101005717B1 (en)
CN (1) CN1642525A (en)
AU (1) AU2003221509B2 (en)
BR (1) BR0308709A (en)
CA (1) CA2479638C (en)
DE (1) DE10214264A1 (en)
EA (1) EA008610B1 (en)
EC (1) ECSP045322A (en)
HR (1) HRP20040890A2 (en)
IL (1) IL163696A0 (en)
ME (1) ME00246B (en)
MX (1) MXPA04009338A (en)
NO (1) NO20044004L (en)
NZ (1) NZ536030A (en)
PL (1) PL371295A1 (en)
RS (1) RS52481B (en)
UA (1) UA79776C2 (en)
WO (1) WO2003082244A2 (en)
ZA (1) ZA200405637B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008540367A (en) * 2005-05-02 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング New crystalline tiotropium bromide
WO2006117299A2 (en) * 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Novel crystalline forms of tiotropium bromide
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
AU2015201037C1 (en) * 2009-05-29 2017-07-27 Pearl Therapeutics, Inc. Respiratory delivery of active agents
PL3111927T3 (en) 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Compositions for respiratory delivery of active agents and associated methods and systems
SG11201507286QA (en) 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials
CN114712337A (en) * 2016-09-19 2022-07-08 墨西哥氟石股份公司 Pharmaceutical composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (en) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them
JP4672143B2 (en) * 1998-08-04 2011-04-20 ヤゴテック アーゲー Pharmaceutical aerosol formulation
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
JP2004512379A (en) * 2000-10-31 2004-04-22 ベーリンガー　インゲルハイム　ファルマ　ゲゼルシャフト　ミット　ベシュレンクテル　ハフツング　ウント　コンパニー　コマンディトゲゼルシャフト New pharmaceutical composition
DE10113366A1 (en) * 2001-03-20 2002-09-26 Boehringer Ingelheim Pharma Medicament for treating inflammatory or obstructive respiratory diseases, e.g. asthma or chronic obstructive pulmonary disease, containing synergistic combination of anticholinergic agent and endothelin antagonist
DE10111058A1 (en) * 2001-03-08 2002-09-12 Boehringer Ingelheim Pharma New drug compositions based on anticholinergics and NK¶1¶ receptor antagonists

Also Published As

Publication number Publication date
UA79776C2 (en) 2007-07-25
WO2003082244A2 (en) 2003-10-09
MXPA04009338A (en) 2005-01-25
EP1492498A2 (en) 2005-01-05
DE10214264A1 (en) 2003-10-16
AU2003221509A1 (en) 2003-10-13
NZ536030A (en) 2006-07-28
CN1642525A (en) 2005-07-20
ME00246B (en) 2011-05-10
BR0308709A (en) 2005-01-04
NO20044004L (en) 2004-10-05
EA008610B1 (en) 2007-06-29
WO2003082244A3 (en) 2004-02-05
CA2479638A1 (en) 2003-10-09
CA2479638C (en) 2011-01-04
YU86004A (en) 2006-08-17
HRP20040890A2 (en) 2005-06-30
IL163696A0 (en) 2005-12-18
PL371295A1 (en) 2005-06-13
MEP47308A (en) 2011-02-10
AU2003221509B2 (en) 2008-01-24
JP2005527550A (en) 2005-09-15
KR101005717B1 (en) 2011-01-05
ZA200405637B (en) 2005-07-27
JP5147158B2 (en) 2013-02-20
EA200401159A1 (en) 2005-04-28
RS52481B (en) 2013-02-28
KR20040098022A (en) 2004-11-18

Similar Documents

Publication Publication Date Title
BR0116444A (en) Process for the preparation of anticholinergic tiotropium bromide
ES2134051T3 (en) PROCEDURE FOR THE PREPARATION OF SILDENAFIL.
MXPA03011197A (en) Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents.
NO20045235L (en) Tetrahydropyranyl cyclopentyltetrahydropyridopyridine modulators with chemokine receptor activity
FI903331A0 (en) KINAZOLINONER SUBSTITUERADE, VILKA AER ANVAENDBARA SOM ANGIOTENSIN-II-ANTAGONISTER.
MX9304647A (en) 7- (REPLACED) -9 - [(REPLACED GLYCIDE) AMIDO] -6-DESMETIL-6-DESOXITETRACICLINAS AND METHOD FOR ITS PRODUCTION.
TW200738672A (en) Intermediated for the preparation of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
IL158485A (en) Spiropyrazole compounds
MX9304646A (en) NEW 7- (REPLACED) -8- (REPLACED) D-9 - [(REPLACED GLYCLE) AMIDO] -6-DESMETIL-6-DESOXITETRACICLINASY METHOD FOR ITS PRODUCTION.
AR006390A1 (en) LACTAMA DERIVATIVES
GB0127903D0 (en) Improvements relating to organic compounds
CY1106247T1 (en) THIOPHEN- AND THIAZOLESULFONAMIDES AS ANTINEOPLASTIC AGENTS
ECSP045322A (en) FORMULATIONS OF AN HID SUSPENSION WITH HFA
AU2003290592A1 (en) Antitumor benzoylsulfonamides
ECSP045321A (en) FORMULATIONS IN SUSPENSION WITH HFA CONTAINING AN ANTICHOLINERGIC
MXPA04003755A (en) Stents.
BR0115139A (en) Bisheterocyclic compounds with antitumor and chemosensitizing activity
MXPA05002639A (en) Silicone rubber.
DE60112325D1 (en) CYCLISATION PROCESS STEP IN THE PREPARATION OF CHINOLONES AND NAPHTHYRIDINES
IL150310A0 (en) Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
PL348509A1 (en) Production of ascorbic acid using yeast
UY26574A1 (en) "PROCEDURE FOR THE ENZYMATIC SEPARATION OF RACEMATES OF AMINOMETIL-ARYL-CYCLOHEXANOL DERIVATIVES".
GB2348423B (en) Novel anhydrofructose antioxidant
ES2093760T3 (en) PROCEDURE FOR THE OBTAINING OF TERTIARY PHOSPHINS.
GB9921578D0 (en) Omeprazole synthesis